Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Research & Development

The Otsuka group has a diverse research and development programme, which aims to create world-class solutions in areas of high unmet need. In 2019 our R&D investment was €1.77 billion. We have a network of 49 research institutes around the world with discovery taking place mostly in Japan and our clinical development conducted worldwide. Otsuka is willing to take the long-term view when it comes to investing in researching diseases and disorders that are difficult to treat. Our portfolio is rich and varied and our freethinking attitude means that we avoid general approaches to product development. This helps us to create the healthcare solutions of tomorrow, as we search for new opportunities in our global research areas of neuroscience, oncology, cardiovascular, renal, gastroenterology, infectious diseases, ophthalmology and dermatology. We are also exploring how digital health technology may provide holistic health solutions for patients, carers and healthcare professionals.

Date of preparation: January 2021 | Reference NOR-NPR-2100001

This website is for all those with an interest in Otsuka Pharmaceutical in the Nordics and BeNeLux.